University of Alberta Empowers Breakthroughs: Assigns Comprehensive Patent Portfolio to 48Hour Discovery
University of Alberta Assigns Full Suite of Patents to 48Hour Discovery as Revenue Exceeds $5 Million Triggering Key Milestone November...
Press Releases
Orano Med and 48Hour Discovery to Develop Innovative Peptide Receptor Radionuclide Therapy for Targeted Cancer Treatment
Advancing Precision Medicine: Uniting 212Pb Alpha-Emitting Radioisotope and Cutting-Edge Peptide Discovery November 6, 2023 – Orano Med, a pioneer in...
48Hour Discovery Reveals New Insight into Cellular Regulation: Breakthrough Discovery for Controlling Cell Activity
New Peptide Motif Crucial for O-GlcNAc Transferase (OGT) Regulation Discovered Promises Far-Reaching Implications for Cell Physiology and Targeted Therapies October...
48Hour Discovery Accepted into Johnson & Johnson Innovation—JLABS
Edmonton-based biotech company advances the discovery and development of novel cancer therapeutics October 17, 2023 – 48Hour Discovery Inc., a...
